D G Gilliland
Overview
Explore the profile of D G Gilliland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
96
Citations
3960
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rice K, Lin X, Wolniak K, Ebert B, Berkofsky-Fessler W, Buzzai M, et al.
Blood Cancer J
. 2012 Jul;
1(11):e40.
PMID: 22829077
Polycythemia vera (PV), essential thrombocythemia and primary myelofibrosis, are myeloproliferative neoplasms (MPNs) with distinct clinical features and are associated with the JAK2V617F mutation. To identify genomic anomalies involved in the...
2.
Wernig G, Kharas M, Mullally A, Leeman D, Okabe R, George T, et al.
Leukemia
. 2011 Oct;
26(4):720-7.
PMID: 22005786
About 10% of patients with essential thrombocythemia (ET) or myelofibrosis (MF) that lack mutations in JAK2 harbor an activating mutation in the thrombopoietin receptor, MPLW515L. Distinct from the JAK2V617F retroviral...
3.
Abdel-Wahab O, Pardanani A, Patel J, Wadleigh M, Lasho T, Heguy A, et al.
Leukemia
. 2011 Apr;
25(7):1200-2.
PMID: 21455215
No abstract available.
4.
Tefferi A, Lasho T, Abdel-Wahab O, Guglielmelli P, Patel J, Caramazza D, et al.
Leukemia
. 2010 May;
24(7):1302-9.
PMID: 20508616
In a multi-institutional collaborative project, 1473 patients with myeloproliferative neoplasms (MPN) were screened for isocitrate dehydrogenase 1 (IDH1)/IDH2 mutations: 594 essential thrombocythemia (ET), 421 polycythemia vera (PV), 312 primary myelofibrosis...
5.
Heinrichs S, Kulkarni R, Bueso-Ramos C, Levine R, Loh M, Li C, et al.
Leukemia
. 2009 Apr;
23(9):1605-13.
PMID: 19387468
Progress in the management of patients with myelodysplastic syndromes (MDS) has been hampered by the inability to detect cytogenetic abnormalities in 40-60% of cases. We prospectively analyzed matched pairs of...
6.
Wojiski S, Guibal F, Kindler T, Lee B, Jesneck J, Fabian A, et al.
Leukemia
. 2009 Mar;
23(8):1462-71.
PMID: 19322209
Acute promyelocytic leukemia (APL) is characterized by hyperproliferation of promyelocytes, progenitors that are committed to terminal differentiation into granulocytes, making it an ideal disease in which to study the transforming...
7.
Tefferi A, Lim K, Abdel-Wahab O, Lasho T, Patel J, Patnaik M, et al.
Leukemia
. 2009 Mar;
23(7):1343-5.
PMID: 19295549
No abstract available.
8.
Tefferi A, Pardanani A, Lim K, Abdel-Wahab O, Lasho T, Patel J, et al.
Leukemia
. 2009 Mar;
23(5):905-11.
PMID: 19262601
High-throughput DNA sequence analysis was used to screen for TET2 mutations in bone marrow-derived DNA from 239 patients with BCR-ABL-negative myeloproliferative neoplasms (MPNs). Thirty-two mutations (19 frameshift, 10 nonsense, 3...
9.
Tefferi A, Levine R, Lim K, Abdel-Wahab O, Lasho T, Patel J, et al.
Leukemia
. 2009 Mar;
23(5):900-4.
PMID: 19262599
TET2 (TET oncogene family member 2) is a candidate tumor suppressor gene located at chromosome 4q24, and was recently reported to be mutated in approximately 14% of patients with JAK2V617F-positive...
10.
Bernard L, Belisle C, Mollica L, Provost S, Roy D, Gilliland D, et al.
Leukemia
. 2008 Nov;
23(2):287-91.
PMID: 19005480
Myeloproliferative neoplasms (MPNs) are clonal stem cell disorders characterized by chronic proliferation of hematopoietic progenitors. We studied the telomere length (TL) of 335 MPN patients and 93 gender- and age-matched...